"We continued to deliver organic growth and margin expansion, generating solid cash flows from the business." - John Stubbington CEO
The third quarter has been an eventful quarter, during which we announced the divestment of our Indian hospital business, continued to optimise our footprint, and added new fitness facilities and blood-drawing points. We continued to deliver organic growth and margin expansion, generating solid cash flows from the business. Through the divestment of our India hospital business (MHI), we will become a more focused provider across three key European markets, with strengthened financial position and flexibility, making us well positioned for the future.
Quarter in numbers*
Revenue
EUR 570.8 million
EBITDA margin
17.4 %
Operating cash flow (Group total)
EUR 93.8 million
*The figures presented in this report refer to continuing operations unless otherwise stated. The Indian hospital operation is reported as a disposal group held for sale and as a discontinued operation. Group total refers to continuing operations and discontinued operations. The comparative numbers have been restated where applicable.
Medicover in brief
Medicover is a leading healthcare services provider, founded in 1995, and listed on Nasdaq Stockholm since 2017. A holistic approach and commitment to quality drive the company’s mission to improve and sustain health and wellbeing.
Services are delivered through two divisions:
Healthcare Services and Diagnostic Services.
Healthcare Services
Healthcare Services – provides a broad range of high-quality healthcare services, including outpatient and inpatient healthcare, dentistry, fertility treatments and wellbeing solutions such as sports. Services can be financed by employer-paid subscriptions, by patients themselves on a fee-for-service (FFS) basis, or through public or private health insurance.
Diagnostic Services
Diagnostic Services – provides comprehensive clinical laboratory services across all major areas of clinical pathology, from routine screenings to advanced testing, supporting everything from disease prevention to treatment monitoring. Operations are carried out through a network of laboratories, blood-drawing points and clinics across 15 countries, with key markets in Germany, Romania and Poland.
Medicover’s sustainability approach
Sustainability is an integral part of Medicover’s business model and long-term value creation. The company's efforts focus on providing accessible, high-quality healthcare, reducing our environmental impact, and ensuring responsible business practices across the organisation. Medicover’s sustainability work covers environmental, social and governance matters and is reported annually in the company’s Annual Report, which is available here:
